SALT LAKE CITY, UT -- (MARKET WIRE) -- September 13, 2006 -- BSD Medical Corp. (AMEX: BSM) has developed a powerful new system designed to kill cancer through precision-guided microwave thermal ablation of cancerous tissue. The new system, the MicroThermX 100, incorporates advanced features and capabilities made possible by years of research, design and development in the discipline of thermal medicine technology at BSD Medical, supported by many leading research centers throughout the world. The MicroThermX 100 is intended to broadly expand BSD Medical’s market for thermal medicine systems in cancer treatment by also including certain cancers that can be treated through heat alone. Today BSD Medical reviewed some of its breakthrough technological developments in the new MicroThermX 100 design that set a new standard for treatment of cancer through thermal ablation.
